Praluent Vs. Repatha: Interactive Timeline Of Regulatory Milestones
Executive Summary
Many key milestones in PCSK9 inhibitors' development happened within months or weeks of each other; as products reached FDA and edged toward approval, that separation narrowed to days and even hours.